glp-1 roche Ad hoc announcement pursuant to Art. 53 LR] announces positive Phase I results of its oral receptor agonist CT-996 for the treatment of people with obesity ⚡️ 𝗥𝗼𝗰𝗵𝗲 𝗷𝘂𝘀𝘁 𝗽𝗼𝘀𝘁𝗲𝗱 𝗣𝗵𝗮𝘀𝗲

Decreases oxyradical damage - Glutathione detoxifies reactive oxygen radicals by giving them an electron which effectively neutralizes them, or glutathione joins with the oxyradical which again neutralizes it

Cagrilintide acts through the amylin system agonism at amylin/calcitonin receptors a pathway entirely separate from the incretins

For example, a study by Meydani et al., (43) investigated the protective effect of vitamin E supplementation on exercise-induced oxidative damage

GLP-1s support overall cardiometabolic health and help reduce the risk of conditions like heart disease and sleep apnea before they develop, he explains

The compound goes subcutaneously into fat tissue, enters circulation directly, and gets distributed throughout the body